Virtual Frontiers in Science: A New Horizon in Precision Oncology – Proteogenomics
Join Henry Rodriguez, Ph.D., Director, Office of Cancer Clinical Proteomics Research, National Cancer Institute, National Institutes of Health, Senior Scientific Officer for this Frontiers in Science Virtual Lecture.
Massive analysis of cancer genomics data from thousands of tumors from all major cancer types has facilitated the molecular classification of cancer in modern medicine, guiding a precision oncology approach for patients. However, the advances in precision oncology have drawbacks and limitations as the needs of many cancer patients remain unaddressed. Integration of proteomics data with genomics data (proteogenomics) facilitates to advance our understanding of the causes of cancer and narrow target selection for potential therapeutic intervention by providing increased granularity regarding cancer-relevant pathways. As such, proteogenomics provides an opportunity to generate new insights by melding the complexity of cancer genomics with cancer proteomics to more completely understand how somatic genomes activate aberrant signal transduction events that drive cancer pathogenesis, with the potential to fast become an essential part of laboratory medicine. This seminar will discuss how genomics, transcriptomics, and proteomics are being combined in the quest to understand the etiology of cancer – in basic clinical sample studies and translational research (clinical trials).
Learn more about the FAU Frontiers in Science Public Lecture Series at: http://www.science.fau.edu/frontiers. Register and join the talk here: https://fau-edu.zoom.us/webinar/register/WN_Hh12Itn2TlyMVF8urOK0ww.